01 1W. R. Grace & Co.-Conn.
01 1para- Aminohippuric Acid
01 1U.S.A
NDC Package Code : 22568-1010
Start Marketing Date : 2021-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
77
PharmaCompass offers a list of Aminohippuric Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Aminohippuric Acid manufacturer or Aminohippuric Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Aminohippuric Acid manufacturer or Aminohippuric Acid supplier.
PharmaCompass also assists you with knowing the Aminohippuric Acid API Price utilized in the formulation of products. Aminohippuric Acid API Price is not always fixed or binding as the Aminohippuric Acid Price is obtained through a variety of data sources. The Aminohippuric Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Paha manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Paha, including repackagers and relabelers. The FDA regulates Paha manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Paha API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Paha supplier is an individual or a company that provides Paha active pharmaceutical ingredient (API) or Paha finished formulations upon request. The Paha suppliers may include Paha API manufacturers, exporters, distributors and traders.
click here to find a list of Paha suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Paha as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Paha API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Paha as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Paha and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Paha NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Paha suppliers with NDC on PharmaCompass.
